PCK1 and metabolic dysfunction-associated steatohepatitis: Since patients with DM, especially those with insulin resistance, often complicate nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, there is a high chance of PCK1 leaking from live cells, which might produce antibodies against PCK1 [30].